Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Tanner

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Neurology|March 1, 1994
Managing motor fluctuations, dyskinesias, and other adverse effects in Parkinson's diseaseC M Tanner, E Melamed, A J Lees
Neurology|January 1, 1986
Autonomic dysfunction in Parkinson's diseaseC G Goetz, W Lutge, C M Tanner
Clinical Neuropharmacology|January 1, 1986
Myoclonus and parkinsonismH L Klawans, C M Tanner, J McDermott
Neurology|July 1, 1982
Meige disease: acute and chronic cholinergic effectsC M Tanner, R H Glantz, H L Klawans
Clinical Neuropharmacology|April 1, 1991
Aluminum neurotoxicity: a reevaluationJ C Murray, C M Tanner, S M Sprague
Advances in Neurology|January 1, 1988
Epidemiology and pathophysiology of tardive dyskinesiasH L Klawans, C M Tanner, C G Goetz
Neurology|April 1, 1987
Progression of Parkinson's disease without levodopaC G Goetz, C M Tanner, K M Shannon
Clinical Neuropharmacology|December 1, 1982
Drug holiday in the management of Parkinson diseaseC G Goetz, C M Tanner, H L Klawans
Advances in Neurology|January 1, 1988
Efficacy of cervical cord stimulation in dystoniaC G Goetz, R D Penn, C M Tanner
Archives of Neurology|March 1, 1984
Fluphenazine and multifocal tic disordersC G Goetz, C M Tanner, H L Klawans
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Neurology|March 1, 1994
Managing motor fluctuations, dyskinesias, and other adverse effects in Parkinson's diseaseC M Tanner, E Melamed, A J Lees
Neurology|January 1, 1986
Autonomic dysfunction in Parkinson's diseaseC G Goetz, W Lutge, C M Tanner
Clinical Neuropharmacology|January 1, 1986
Myoclonus and parkinsonismH L Klawans, C M Tanner, J McDermott
Neurology|July 1, 1982
Meige disease: acute and chronic cholinergic effectsC M Tanner, R H Glantz, H L Klawans
Clinical Neuropharmacology|April 1, 1991
Aluminum neurotoxicity: a reevaluationJ C Murray, C M Tanner, S M Sprague
Advances in Neurology|January 1, 1988
Epidemiology and pathophysiology of tardive dyskinesiasH L Klawans, C M Tanner, C G Goetz
Neurology|April 1, 1987
Progression of Parkinson's disease without levodopaC G Goetz, C M Tanner, K M Shannon
Clinical Neuropharmacology|December 1, 1982
Drug holiday in the management of Parkinson diseaseC G Goetz, C M Tanner, H L Klawans
Advances in Neurology|January 1, 1988
Efficacy of cervical cord stimulation in dystoniaC G Goetz, R D Penn, C M Tanner
Archives of Neurology|March 1, 1984
Fluphenazine and multifocal tic disordersC G Goetz, C M Tanner, H L Klawans
Pageof 14